Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.
Autorzy:
Wirchnianski AS; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America. Nyakatura EK; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America. Herbert AS; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America. Kuehne AI; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America. Abbasi SA; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America. Florez C; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America. Storm N; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America. McKay LGA; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America. Dailey L; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America. Kuang E; The Geneva Foundation, Tacoma, Washington, United States of America. Abelson DM; The Geneva Foundation, Tacoma, Washington, United States of America. Wec AZ; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America. Chakraborti S; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America. Holtsberg FW; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America. Shulenin S; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America. BornholdtZA; Mapp Biopharmaceutical Inc., San Diego, California, United States of America. Aman MJ; Mapp Biopharmaceutical Inc., San Diego, California, United States of America. Honko AN; The Geneva Foundation, Tacoma, Washington, United States of America. Griffiths A; The Geneva Foundation, Tacoma, Washington, United States of America. Dye JM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America. Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America. Lai JR; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Apr 11; Vol. 20 (4), pp. e1012134. Date of Electronic Publication: 2024 Apr 11.
Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies.
Autorzy:
Mishra AK; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA. Hellert J; Institut Pasteur, Université de Paris, CNRS UMR 3569, Structural Virology Unit, 25-28 rue du Docteur Roux, Cedex 15, Paris, 75724 France. Freitas N; CIRI-Centre International de Recherche en Infectiologie, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, Lyon, 69007 France. Guardado-Calvo P; Institut Pasteur, Université de Paris, CNRS UMR 3569, Structural Virology Unit, 25-28 rue du Docteur Roux, Cedex 15, Paris, 75724 France. Haouz A; Institut Pasteur, Université de Paris, CNRS UMR 3528, Crystallography Platform C2RT, 25-28 rue du Docteur Roux, Cedex 15, Paris, 75724 France. Fels JM; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Maurer DP; Adimab LLC, Lebanon, NH 03766, USA. Abelson DM; Mapp Biopharmaceutical Inc., San Diego, CA 92121, USA. BornholdtZA; Mapp Biopharmaceutical Inc., San Diego, CA 92121, USA. Walker LM; Adimab LLC, Lebanon, NH 03766, USA. Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Cosset FL; CIRI-Centre International de Recherche en Infectiologie, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, 46 allée d'Italie, Lyon, 69007 France. McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA. Rey FA; Institut Pasteur, Université de Paris, CNRS UMR 3569, Structural Virology Unit, 25-28 rue du Docteur Roux, Cedex 15, Paris, 75724 France.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2022 Jan 07; Vol. 375 (6576), pp. 104-109. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses.
Autorzy:
Wec AZ; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Nyakatura EK; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA. Howell KA; Integrated Biotherapeutics Inc., Gaithersburg, MD 20878, USA. Holtsberg FW; Integrated Biotherapeutics Inc., Gaithersburg, MD 20878, USA. Bakken RR; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA. Mittler E; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Christin JR; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Shulenin S; Integrated Biotherapeutics Inc., Gaithersburg, MD 20878, USA. Jangra RK; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Bharrhan S; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Kuehne AI; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA. BornholdtZA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 10550, USA. Flyak AI; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN 37235, USA. Saphire EO; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 10550, USA.; The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 10550, USA. Crowe JE Jr; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN 37235, USA. .; Department of Pediatrics, Vanderbilt University, Nashville, TN 37232, USA.; Vanderbilt Vaccine Center, Vanderbilt University, Nashville, TN 37232, USA. Aman MJ; Integrated Biotherapeutics Inc., Gaithersburg, MD 20878, USA. . Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA. . Lai JR; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA. . Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. .
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2016 Oct 21; Vol. 354 (6310), pp. 350-354. Date of Electronic Publication: 2016 Sep 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak.
Autorzy:
BornholdtZA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA. Turner HL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Murin CD; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA. Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Li W; Adimab, Lebanon, NH 03766, USA. Sok D; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA. Souders CA; MassBiologics, University of Massachusetts Medical School, Boston, MA 02126, USA. Piper AE; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. Goff A; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. Shamblin JD; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. Wollen SE; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. Sprague TR; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. Fusco ML; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA. Pommert KB; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA. Cavacini LA; MassBiologics, University of Massachusetts Medical School, Boston, MA 02126, USA. Smith HL; MassBiologics, University of Massachusetts Medical School, Boston, MA 02126, USA. Klempner M; MassBiologics, University of Massachusetts Medical School, Boston, MA 02126, USA. Reimann KA; MassBiologics, University of Massachusetts Medical School, Boston, MA 02126, USA. Krauland E; Adimab, Lebanon, NH 03766, USA. Gerngross TU; Adimab, Lebanon, NH 03766, USA. Wittrup KD; Adimab, Lebanon, NH 03766, USA. Saphire EO; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA. Burton DR; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA. Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA 02142, USA. Glass PJ; U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Walker LM; Adimab, Lebanon, NH 03766, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2016 Mar 04; Vol. 351 (6277), pp. 1078-83. Date of Electronic Publication: 2016 Feb 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies